NOVI, GIOVANNI
 Distribuzione geografica
Continente #
EU - Europa 2.760
AS - Asia 389
NA - Nord America 168
SA - Sud America 38
AF - Africa 10
OC - Oceania 3
Totale 3.368
Nazione #
IT - Italia 2.701
SG - Singapore 169
US - Stati Uniti d'America 154
CN - Cina 87
VN - Vietnam 81
BR - Brasile 22
FR - Francia 22
FI - Finlandia 13
AR - Argentina 10
HK - Hong Kong 10
CA - Canada 8
GB - Regno Unito 8
JP - Giappone 7
BD - Bangladesh 6
SA - Arabia Saudita 5
DE - Germania 4
PK - Pakistan 4
UZ - Uzbekistan 4
IN - India 3
MX - Messico 3
NL - Olanda 3
ZA - Sudafrica 3
AU - Australia 2
AZ - Azerbaigian 2
CH - Svizzera 2
EG - Egitto 2
MA - Marocco 2
PY - Paraguay 2
RU - Federazione Russa 2
BE - Belgio 1
BH - Bahrain 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
ES - Italia 1
ET - Etiopia 1
GE - Georgia 1
GN - Guinea 1
GR - Grecia 1
HT - Haiti 1
ID - Indonesia 1
IQ - Iraq 1
JO - Giordania 1
KE - Kenya 1
LT - Lituania 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
TR - Turchia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 3.368
Città #
Genova 1.090
Genoa 1.046
Rapallo 289
Vado Ligure 248
Singapore 86
San Jose 61
Ho Chi Minh City 32
Beijing 21
Hanoi 21
Lauterbourg 20
Helsinki 13
Ashburn 12
Hong Kong 9
Council Bluffs 7
Tokyo 7
Haiphong 5
Savona 5
Frankfurt am Main 4
New York 4
Tashkent 4
Buffalo 3
Chicago 3
Johannesburg 3
Mexico City 3
Montreal 3
Rome 3
Santa Clara 3
São Paulo 3
Tianjin 3
Amsterdam 2
Asunción 2
Atlanta 2
Baku 2
Bari 2
Can Tho 2
Dhaka 2
Jeddah 2
Karachi 2
Los Angeles 2
Lấp Vò 2
Phủ Lý 2
Riyadh 2
Sydney 2
Zurich 2
Altamira 1
Amman 1
Auckland 1
Bahir Dar 1
Barra 1
Belo Horizonte 1
Bengaluru 1
Biên Hòa 1
Blackshear 1
Bologna 1
Bordighera 1
Brescia 1
Brest 1
Buenos Aires 1
Bắc Giang 1
Bắc Ninh 1
Cairo 1
Canoas 1
Cardiff 1
Casimiro de Abreu 1
City of London 1
Conakry 1
Cotia 1
Criciúma 1
Curitiba 1
Da Nang 1
Dammam 1
El Galpón 1
Erbil 1
Faisalabad 1
Feni 1
Fortaleza 1
Frutal 1
Grand Bourg 1
Guangzhou 1
Guayaquil 1
Hamad Town 1
Hershey 1
Hull 1
Hải Dương 1
Igarassu 1
Indore 1
Jandira 1
Jhelum 1
Kalamata 1
Lanús 1
Limassol 1
Liège 1
Lomas de Zamora 1
London 1
Luján de Cuyo 1
Managua 1
Maracaibo 1
Marseille 1
Marília 1
Mayfield 1
Totale 3.097
Nome #
Different MRI patterns in MS worsening after stopping fingolimod 199
Clinical epidemiology of amyotrophic lateral sclerosis in Liguria, Italy: An update of LIGALS register 198
Ghost spasticity in multiple sclerosis 185
A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis 178
Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS 176
The therapeutic effect of mesenchymal stem cell transplantation in experimental autoimmune encephalomyelitis is mediated by peripheral and central mechanisms 169
Dramatic rebounds of MS during pregnancy following fingolimod withdrawal. 169
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience 155
Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders 144
Longitudinal brain magnetic resonance imaging and real-time quaking induced conversion analysis in presymptomatic Creutzfeldt-Jakob disease 141
Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS 137
Tocilizumab in MOG-antibody spectrum disorder: a case report 131
Impact of treatment on cellular immunophenotype in MS: A cross-sectional study 123
Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBS 121
Assessing upper limb function in Multiple Sclerosis by an engineered glove 120
Interleukin-6 Receptor Blockade in Treatment- Refractory MOG-Ab–Associated Disease and Neuromyelitis Optica Spectrum Disorders 117
Towards clinical application of mesenchymal stem cells for treatment of neurological diseases of the central nervous system. 106
Fulminant Hepatitis Associated with Echovirus 25 during Treatment with Ocrelizumab for Multiple Sclerosis 101
Alpha-synuclein seeds in olfactory mucosa and cerebrospinal fluid of patients with dementia with Lewy bodies 99
COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role? 96
Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis 95
Tailoring B cell depletion therapy in MS according to memory B cell monitoring 92
Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic? 86
Relationship Between Retinal Layer Thickness and Disability Worsening in Relapsing-Remitting and Progressive Multiple Sclerosis 83
Brain lesion microstructure in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein disease 73
Ocrelizumab in MS patients with persistence of disease activity after alemtuzumab: A multi-center Italian study 70
Vaccinations in patients with multiple sclerosis: a real-world, single-center experience 47
Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: a multicentre retrospective study 35
Totale 3.446
Categoria #
all - tutte 12.587
article - articoli 12.163
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.750


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202152 0 0 0 0 0 0 0 0 0 25 14 13
2021/2022263 7 7 12 23 14 17 11 59 13 30 29 41
2022/2023349 32 32 8 42 39 55 2 20 56 4 52 7
2023/2024272 12 22 3 32 19 58 49 9 15 15 8 30
2024/2025677 50 42 14 46 77 62 88 132 36 18 63 49
2025/2026998 170 24 64 69 185 55 184 48 114 85 0 0
Totale 3.446